🔗 Visit the ClinicalTrials.gov page for NCT02267343
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. | Oncoimmunology | 2015 | 1.06 |
| 2 | Targeted therapies in gastric cancer and future perspectives. | World J Gastroenterol | 2016 | 0.86 |
| 3 | The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1. | J Gastrointest Oncol | 2016 | 0.83 |
| 4 | New advances in targeted gastric cancer treatment. | World J Gastroenterol | 2016 | 0.81 |
| 5 | Gastric cancer: The times they are a-changin'. | World J Gastrointest Oncol | 2015 | 0.79 |
| 6 | Novel therapy for advanced gastric cancer. | World J Gastrointest Oncol | 2015 | 0.75 |